Stock Fundamentals

Company Information

Company Name
Altimmune Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US02155H2004
CIK: 0001326190
CUSIP: 42224H203
Currency: USD
Full Time Employees: 59
Phone: 240 654 1450
Fiscal Year End: December
IPO Date: Oct 06, 2005
Description:

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Address:

910 Clopper Road, Gaithersburg, MD, United States, 20878

Directors & Officers

Name Title Year Born
Dr. M. Scot Roberts Ph.D. Chief Scientific Officer 1959
Mr. Jerome Benedict Durso Chairman, CEO & President 1968
Mr. Gregory L. Weaver CPA, M.B.A. Chief Financial Officer 1956
Mr. Andrew Shutterly M.S. Principal Financial & Accounting Officer and Corporate Controller 1988
Mr. Bertrand Georges Ph.D. Chief Technology Officer NA
Mr. Tony Blandin B.S. Vice President of Quality & Compliance Management NA
Ms. Robin E. Abrams J.D. General Counsel & Chief Legal Officer 1964
Mr. Raymond M. Jordt M.B.A. Chief Business Officer 1973
Ms. Linda M. Richardson Chief Commercial Officer 1964
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D. Chief Medical Officer 1962

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 9.49M Dec 31, 2025 7.58% $0.00 48.91%
BlackRock Inc 6.37M Sep 30, 2025 5.09% $0.00 0.01%
State Street Corp 3.60M Sep 30, 2025 2.88% $0.00 30.78%
TANG CAPITAL MANAGEMENT LLC 2.13M Sep 30, 2025 1.70% $0.31 -22.50%
Geode Capital Management, LLC 2.02M Sep 30, 2025 1.61% $0.00 4.26%
Morgan Stanley - Brokerage Accounts 1.49M Sep 30, 2025 1.19% $0.00 78.48%
Susquehanna International Group, LLP 1.37M Sep 30, 2025 1.10% $0.00 -15.16%
D. E. Shaw & Co LP 1.34M Dec 31, 2025 1.07% $0.00 272.81%
Citadel Advisors Llc 1.28M Sep 30, 2025 1.02% $0.00 144.91%
Two Sigma Investments LLC 1.27M Dec 31, 2025 1.01% $0.01 -36.62%
Knoll Capital Management LP 1.12M Dec 31, 2025 0.90% $1.86 0.00%
Two Sigma Advisers, LLC 793.90K Dec 31, 2025 0.63% $0.01 -44.42%
Northern Trust Corp 657.02K Sep 30, 2025 0.52% $0.00 2.60%
UBS Group AG 642.84K Sep 30, 2025 0.51% $0.00 -27.52%
FMR Inc 564.09K Dec 31, 2025 0.45% $0.00 26.72%
The Goldman Sachs Group Inc 562.26K Sep 30, 2025 0.45% $0.00 12.62%
Point72 Asset Management, L.P. 476.93K Sep 30, 2025 0.38% $0.00 0.00%
Schroder Investment Management Group 469.01K Dec 31, 2025 0.37% $0.00 0.00%
Beirne Wealth Consulting Services, LLC 410.46K Sep 30, 2025 0.33% $0.37 19.86%
Soviero Asset Management, LP 400.00K Dec 31, 2025 0.32% $0.69 0.00%

Shares Statistics

Shares Outstanding: 125.23M
Shares Float: 103.53M
% Insiders: 72.30%
% Institutions: 4,892.40%
Short % Float: 20.17%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 9.49M 7.58% ▲ 48.91% Dec 31, 2025
2 BlackRock Inc 6.37M 5.09% ▲ 0.01% Sep 30, 2025
3 State Street Corp 3.60M 2.88% ▲ 30.78% Sep 30, 2025
4 TANG CAPITAL MANAGEMENT LLC 2.13M 1.70% ▼ 22.50% Sep 30, 2025
5 Geode Capital Management, LLC 2.02M 1.61% ▲ 4.26% Sep 30, 2025
6 Morgan Stanley - Brokerage Accounts 1.49M 1.19% ▲ 78.48% Sep 30, 2025
7 Susquehanna International Group, LLP 1.37M 1.10% ▼ 15.16% Sep 30, 2025
8 D. E. Shaw & Co LP 1.34M 1.07% ▲ 272.81% Dec 31, 2025
9 Citadel Advisors Llc 1.28M 1.02% ▲ 144.91% Sep 30, 2025
10 Two Sigma Investments LLC 1.27M 1.01% ▼ 36.62% Dec 31, 2025

Valuation Metrics

Enterprise Value: $343.62M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $539.75M
EBITDA: $-90.34M
PEG Ratio: $0.00
Book Value: $1.94
Earnings/Share: $-1.07
Profit Margin: 0.00%
Operating Margin: -417,180.00%
ROA (TTM): -30.87%
ROE (TTM): -52.62%
Revenue (TTM): $20.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 13.11x 0.00x 0.11x -11,463.56x 0.00x
2023-12-31 17.26x 0.00x 0.08x -2,740.83x -0.01x
2022-12-31 11.31x 0.00x 0.10x -10,967.50x -0.01x
2021-12-31 11.17x 0.01x 0.09x -19,382.80x -0.02x
2020-12-31 19.16x 0.01x 0.08x -5,816.66x -0.06x
2019-12-31 10.04x 0.05x 0.16x -9,565.48x -0.11x
2018-12-31 8.70x 0.04x 0.12x -144.18x -0.04x
2017-12-31 6.11x 0.09x 0.23x -320.99x -0.09x
2016-12-31 1.09x 0.10x 0.91x -292.59x -0.18x
2015-12-31 7.90x 0.03x 0.16x -62.34x -0.18x
2014-12-31 7.46x 0.04x 0.17x -48.44x -0.08x
2013-12-31 2.11x 0.38x 0.57x -29.35x -0.25x
2012-12-31 2.64x 0.32x 0.49x -18.29x -0.93x
2011-12-31 4.25x 0.00x 0.30x -214.86x 0.00x
2010-12-31 3.83x 0.00x 0.55x -3.97x 0.00x
2009-12-31 1.80x 0.00x 0.94x -9.15x 0.00x
2008-12-31 1.29x 0.92x 0.66x -13.70x -0.53x
2007-12-31 6.50x 0.10x 0.39x -7.78x -0.25x
2006-12-31 68.57x 0.00x 0.20x N/A 0.08x
2005-12-31 170.72x 0.00x 0.01x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 08, 2026 Wayne Pisano N/A Purchase 5.00K $4.08 $20.40K
Dec 29, 2025 Diane Jorkasky N/A Purchase 527.00 $3.80 $2.00K
Dec 23, 2025 John Gill N/A Purchase 12.50K $4.10 $51.25K
Dec 22, 2025 Jerome Benedict Durso N/A Purchase 12.50K $4.13 $51.63K
Mar 13, 2025 Gregory L Weaver N/A Purchase 10.00K $5.20 $52.00K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ALT.US!